Your browser doesn't support javascript.
loading
MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
Shetty, Sindhu; Habeeb, Omar; Rivera, Christine; Astbury, Caroline; Przybycin, Christopher; Joehlin-Price, Amy S.
Afiliação
  • Shetty S; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA.
  • Habeeb O; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA.
  • Rivera C; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA.
  • Astbury C; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA.
  • Przybycin C; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA.
  • Joehlin-Price AS; Cleveland Clinic Pathology and Laboratory Medicine Institute, Cleveland, OH, 44195, USA. Electronic address: joehlia@ccf.org.
Hum Pathol ; 117: 42-50, 2021 11.
Article em En | MEDLINE | ID: mdl-34391746

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Tumor de Brenner / Carcinoma de Células de Transição / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-mdm2 Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Tumor de Brenner / Carcinoma de Células de Transição / Biomarcadores Tumorais / Proteínas Proto-Oncogênicas c-mdm2 Tipo de estudo: Diagnostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article